Authors: Tognoni, A.; Cadenotti, L.; Pensa, F.; Vaira, F.; Vigani, A.; Bancalari, L.; Cordani, S.; Maggiani, R.; Canessa, P.A.; Pronzato, P.

Source: Journal of Chemotherapy, Volume 11, Number 4, 1999 , pp. 306-309(4)

Publisher: Maney Publishing

Abstract:

Twenty-nine patients with advanced non-small-cell lung cancer (NSCLC) were treated with a combination of cisplatin 20 mg/m² days 1-3, ifosfamide 1500 mg/m² days 1-2 (plus mesna as uroprotector) and vinorelbine 25 mg/m² days 1 and 5; filgrastim was given at the dose of 300 μg subcutaneously from day 8 to day 15. A response rate of 28% was observed. The activity of this combination in an outpatient setting, with acceptable toxicity, has been demonstrated.

Document Type: Research Article

Publication date: 1999-01-01

More about this publication?

• Editorial Board
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Information for Advertisers
• Terms & Conditions
• Top Articles
• Abstracted in
• Sign up for e-alerts
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• By this author: Tognoni, A. ;  Cadenotti, L. ;  Pensa, F. ;  Vaira, F. ;  Vigani, A. ;  Bancalari, L. ;  Cordani, S. ;  Maggiani, R. ;  Canessa, P.A. ;  Pronzato, P.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers